Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Terre, C; Bastie, JN; Garcia, I; Suzan, F; Cayuela, JM; Therond, P; Castaigne, S
   BCR/ABL fusion gene detected on 9q34 by fluorescence in situ hybridizationin an acute leukemia with two BCR/ABL positive clones, one Ph-negative andone Ph-positive
   CANCER GENETICS AND CYTOGENETICS
   
   C. Terre et al., "BCR/ABL fusion gene detected on 9q34 by fluorescence in situ hybridizationin an acute leukemia with two BCR/ABL positive clones, one Ph-negative andone Ph-positive", CANC GENET, 131(1), 2001, pp. 37-41
2. Suzan, F; Terre, C; Garcia, I; Bastie, JN; Baumelou, E; Gluckman, E; Castaigne, S
   Three cases of typical aplastic anaemia associated with a Philadelphia chromosome
   BRITISH JOURNAL OF HAEMATOLOGY
   
   F. Suzan et al., "Three cases of typical aplastic anaemia associated with a Philadelphia chromosome", BR J HAEM, 112(2), 2001, pp. 385-387
3. Hofmann, WK; Kell, WJ; Fenaux, P; Castaigne, S; Ganser, A; Chomienne, C; Burnett, R; Kowal, C; Hoelzer, D; Burnett, AK
   Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study
   LEUKEMIA
   
   W.K. Hofmann et al., "Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study", LEUKEMIA, 14(9), 2000, pp. 1583-1588
4. Fenaux, P; Chevret, S; Guerci, A; Fegueux, N; Dombret, H; Thomas, X; Sanz, M; Link, H; Maloisel, F; Gardin, C; Bordessoule, D; Stoppa, AM; Sadoun, A; Muus, P; Wandt, H; Mineur, P; Whittaker, JA; Fey, M; Daniel, MT; Castaigne, S; Degos, L
   Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia
   LEUKEMIA
   
   P. Fenaux et al., "Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia", LEUKEMIA, 14(8), 2000, pp. 1371-1377
5. de Botton, S; Chevret, S; Sanz, M; Dombret, H; Thomas, X; Guerci, A; Fey, M; Rayon, C; Huguet, F; Sotto, JJ; Gardin, C; Makhoul, PC; Travade, P; Solary, E; Fegueux, N; Bordessoule, D; San Miguel, J; Link, H; Desablens, B; Stamatoullas, A; Deconinck, E; Geiser, K; Hess, U; Maloisel, F; Castaigne, S; Preudhomme, C; Chomienne, C; Degos, L; Fenaux, P
   Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial
   BRITISH JOURNAL OF HAEMATOLOGY
   
   S. de Botton et al., "Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial", BR J HAEM, 111(3), 2000, pp. 801-806
6. Bastie, JN; Cazals-Hatem, D; Daniel, MT; D'Agay, MF; Rabian, CL; Glaisner, S; Noel-Walter, MP; Dabout, D; Flandrin, G; Dombret, H; Poisson, D; Degos, L; Castaigne, S
   Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: Evaluation of minimal residual disease and CD4+lymphocytopenia after treatment
   LEUKEMIA & LYMPHOMA
   
   J.N. Bastie et al., "Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: Evaluation of minimal residual disease and CD4+lymphocytopenia after treatment", LEUK LYMPH, 35(5-6), 1999, pp. 555-565
7. Bouabdallah, R; Lefrere, F; Rose, C; Chaibi, P; Harousseau, JL; Vernant, JP; Castaigne, S; Bauduer, F; Zini, JM; Coso, D; Varet, B; Robert, J; Fenaux, P
   A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients
   LEUKEMIA
   
   R. Bouabdallah et al., "A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients", LEUKEMIA, 13(10), 1999, pp. 1491-1496
8. Terre, C; Garcia, I; Bastie, JN; Mayeur, D; Decombe, L; Gruyer, P; Berger, R; Castaigne, S
   A case of chronic neutrophilic leukemia with deletion (11)(q23)
   CANCER GENETICS AND CYTOGENETICS
   
   C. Terre et al., "A case of chronic neutrophilic leukemia with deletion (11)(q23)", CANC GENET, 110(1), 1999, pp. 70-71
9. Fenaux, P; Chastang, C; Chevret, S; Sanz, M; Dombret, H; Archimbaud, E; Fey, M; Rayon, C; Huguet, F; Sotto, JJ; Gardin, C; Makhoul, PC; Travade, P; Solary, E; Fegueux, N; Bordessoule, D; San Miguel, J; Link, H; Desablens, B; Stamatoullas, A; Deconinck, E; Maloisel, F; Castaigne, S; Preudhomme, C; Degos, L
   A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia
   BLOOD
   
   P. Fenaux et al., "A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia", BLOOD, 94(4), 1999, pp. 1192-1200
10. MALOISEL F; BENBOUBKER L; CARCEL C; LEDERLIN P; SEDILLOT M; RAPP MJ; GARDEMBAS M; GANHDOUR C; BLANC M; CHRISTIAN B; CASTAIGNE S; CHERON N; CHAUVENET L; DREYFUSS B; SALLES B; MOREAU P; PEGOURIE B; OBERLING F
    HAIRY-CELL LEUKEMIA (HCL) TREATED WITH PENTOSTATIN - RESULTS OF THE FRENCH RETROSPECTIVE STUDY
    British Journal of Haematology
    
    F. Maloisel et al., "HAIRY-CELL LEUKEMIA (HCL) TREATED WITH PENTOSTATIN - RESULTS OF THE FRENCH RETROSPECTIVE STUDY", British Journal of Haematology, 102(1), 1998, pp. 191-191
11. CASTAIGNE S; ARCHIMBAUD A; BORDESSOULE D; TILLY H; DOMBRET H; DEREVEL T; SIMON M; RENOUX M; JANVIER M; GROSBOIS M; DUPRIEZ B; ZINI JM; TERTIAN G; BAY O; FENAUX P; DEGOS L; CHASTANG C
    INTENSIFIED INDUCTION CHEMOTHERAPY INCREASE REMISSION DURATION IN DE-NOVO ACUTE MYELOID-LEUKEMIA (AML) PATIENTS AGED LESS-THAN 50 YEARS - LONG-TERM RESULTS OF LAM-90 TRIAL
    British Journal of Haematology
    
    S. Castaigne et al., "INTENSIFIED INDUCTION CHEMOTHERAPY INCREASE REMISSION DURATION IN DE-NOVO ACUTE MYELOID-LEUKEMIA (AML) PATIENTS AGED LESS-THAN 50 YEARS - LONG-TERM RESULTS OF LAM-90 TRIAL", British Journal of Haematology, 102(1), 1998, pp. 220-220
12. TAKSIN AL; THOMAS X; CASTAIGNE S; ROUSSELOT P; DEGOS L; ARCHIMBAUD E; DOMBRET H
    LIMITS FOR INTENSIFYING INDUCTION THERAPY IN YOUNGER PATIENTS WITH ACUTE MYELOBLASTIC-LEUKEMIA (AML)
    British Journal of Haematology
    
    A.L. Taksin et al., "LIMITS FOR INTENSIFYING INDUCTION THERAPY IN YOUNGER PATIENTS WITH ACUTE MYELOBLASTIC-LEUKEMIA (AML)", British Journal of Haematology, 102(1), 1998, pp. 223-223
13. CHALIBI P; ROUSSELOT P; GLAISNER S; MOUAS H; TAKSIN AL; MICLEA JM; CASTAIGNE S; DEGOS L; DOMBRET H
    MANAGEMENT OF ACUTE MYELOID-LEUKEMIA (AML) IN PATIENTS AGED 80 YEARS OR MORE
    British Journal of Haematology
    
    P. Chalibi et al., "MANAGEMENT OF ACUTE MYELOID-LEUKEMIA (AML) IN PATIENTS AGED 80 YEARS OR MORE", British Journal of Haematology, 102(1), 1998, pp. 224-224
14. KELL WJ; HOFMANN WK; HOELZER D; CHOMIENNE C; GANSER A; FENAUX P; CASTAIGNE S; BURNETT R; BURNETT AK
    9-CIS-RETINOIC ACID TREATMENT FOR MYELODYSPLASIA
    British Journal of Haematology
    
    W.J. Kell et al., "9-CIS-RETINOIC ACID TREATMENT FOR MYELODYSPLASIA", British Journal of Haematology, 101, 1998, pp. 167-167
15. CHAIBI P; ROUSSELOT P; GLAISNER S; MOUAS H; MICLEA JM; CASTAIGNE S; DEGOS L; DOMBRET H
    MANAGEMENT OF ACUTE MYELOID-LEUKEMIA (AML) IN PATIENTS AGED 80 YEARS AND OVER - A SINGLE INSTITUTION EXPERIENCE
    Blood
    
    P. Chaibi et al., "MANAGEMENT OF ACUTE MYELOID-LEUKEMIA (AML) IN PATIENTS AGED 80 YEARS AND OVER - A SINGLE INSTITUTION EXPERIENCE", Blood, 90(10), 1997, pp. 3757-3757
16. FENAUX P; CHASTANG C; SANZ M; THOMAS X; DOMBRET H; LINK H; GUERCI A; FEGUEUX N; SANMIGUEL J; RAYON C; ZITTOUN R; GARDIN C; MALOISEL F; FEY M; TRAVADE P; REIFFERS J; STAMATOULAS A; STOPPA AM; CAILLOT D; LEFRERE F; HAYAT M; CASTAIGNE S; CHOMIENNE C; DEGOS L
    ATRA FOLLOWED BY CHEMOTHERAPY (CT) VS ATRA PLUS CT AND THE ROLE OF MAINTENANCE THERAPY IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - FIRST INTERIM RESULTS OF APL-93 TRIAL
    Blood
    
    P. Fenaux et al., "ATRA FOLLOWED BY CHEMOTHERAPY (CT) VS ATRA PLUS CT AND THE ROLE OF MAINTENANCE THERAPY IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - FIRST INTERIM RESULTS OF APL-93 TRIAL", Blood, 90(10), 1997, pp. 533-533
17. FENAUX P; CHASTANG C; CASTAIGNE S; ARCHIMBAUD E; LINK H; FEY M; GUERCI A; FEGUEUX N; BOWEN D; LOWENBERG B; GARDIN C; MALOISEL F; STAMATOULAS A; STOPPA AM; SADOUN A; JACKY E; GANSER A; AUZANNEAU G; CHOMIENNE C; DEGOS L
    LONG-TERM FOLLOW-UP CONFIRMS THE SUPERIORITY OF ATRA COMBINED WITH CHEMOTHERAPY (CT) OVER CT ALONE IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - (APL-91 TRIAL)
    Blood
    
    P. Fenaux et al., "LONG-TERM FOLLOW-UP CONFIRMS THE SUPERIORITY OF ATRA COMBINED WITH CHEMOTHERAPY (CT) OVER CT ALONE IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - (APL-91 TRIAL)", Blood, 90(10), 1997, pp. 1476-1476
18. COUMAU E; PEYNET J; HARZIC M; BEAL G; CASTAIGNE S; LEVERGER G; FOUCAUD P
    SEVERE PARVOVIRUS B19 INFECTION IN AN IMM UNOCOMPETENT HEMOPHILIAC-A CHILD
    Archives de pediatrie
    
    E. Coumau et al., "SEVERE PARVOVIRUS B19 INFECTION IN AN IMM UNOCOMPETENT HEMOPHILIAC-A CHILD", Archives de pediatrie, 3(1), 1996, pp. 35-39
19. CORNIC M; DELVA L; CASTAIGNE S; LEFEBVRE P; BALITRAND N; DEGOS L; CHOMIENNE C
    ACQUIRED-RESISTANCE TO ALL-TRANS-RETINOIC ACID THERAPY IN ACUTE PROMYELOCYTIC LEUKEMIA
    Onkologie
    
    M. Cornic et al., "ACQUIRED-RESISTANCE TO ALL-TRANS-RETINOIC ACID THERAPY IN ACUTE PROMYELOCYTIC LEUKEMIA", Onkologie, 19, 1996, pp. 10-13
20. GODEAU B; BIERLING P; OKSENHENDLER E; CASTAIGNE S; DECONINCK E; WECHSLER B
    HIGH-DOSE DEXAMETHASONE THERAPY FOR RESISTANT AUTOIMMUNE THROMBOCYTOPENIC PURPURA
    American journal of hematology
    
    B. Godeau et al., "HIGH-DOSE DEXAMETHASONE THERAPY FOR RESISTANT AUTOIMMUNE THROMBOCYTOPENIC PURPURA", American journal of hematology, 51(4), 1996, pp. 334-334
21. FENAUX P; CHASTANG C; SANZ M; ARCHIMBAUD E; DOMBRET H; LINK H; GUERCI A; FEGUEUX N; SANMIGUEL J; RAYON C; ZITTTOUN R; GARDIN C; MALOSIEL F; FEY M; CASTAIGNE S; CHOMIENNE C; DEGOS L
    EFFECT OF ATRA IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - VALIDATION OF SHORT-TERM EFFECT IN A LARGE MULTICENTER TRIAL (APL-93TRIAL) AND ASSESSMENT OF LONG-TERM BENEFIT (APL-91 TRIAL)
    Blood
    
    P. Fenaux et al., "EFFECT OF ATRA IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) - VALIDATION OF SHORT-TERM EFFECT IN A LARGE MULTICENTER TRIAL (APL-93TRIAL) AND ASSESSMENT OF LONG-TERM BENEFIT (APL-91 TRIAL)", Blood, 88(10), 1996, pp. 824-824
22. CASTAIGNE S; ARCHIMBAUD E; BORDESSOULE D; FENAUX P; TILLY H; DEREVEL T; SIMON M; JANVIER M; RENOUX M; GROSBOIS B; DUPRIEZ B; ZINI JM; TERTIAN G; LEGROS M; CHASTANG C; DEGOS L
    SEQUENTIAL INDUCTION OR DOUBLE INDUCTION CHEMOTHERAPY INCREASE DISEASE-FREE SURVIVAL COMPARED TO 3-CHEMOTHERAPY IN LESS-THAN 50 YEARS ADULTS WITH ACUTE MYELOID-LEUKEMIA (AML)(7)
    Blood
    
    S. Castaigne et al., "SEQUENTIAL INDUCTION OR DOUBLE INDUCTION CHEMOTHERAPY INCREASE DISEASE-FREE SURVIVAL COMPARED TO 3-CHEMOTHERAPY IN LESS-THAN 50 YEARS ADULTS WITH ACUTE MYELOID-LEUKEMIA (AML)(7)", Blood, 88(10), 1996, pp. 1153-1153
23. BASTIE JN; DANIEL MT; CAZALSHATEM D; NIEZ P; DABOUT D; GLAISNER S; DAGAY MF; FLANDRIN G; DEGOS L; CASTAIGNE S
    LONG-TERM FOLLOW-UP AFTER 2-CHLORODEOXYADENOSINE (2CDA) TREATMENT IN 30 PATIENTS WITH HAIRY-CELL LEUKEMIA (HCL)
    Blood
    
    J.N. Bastie et al., "LONG-TERM FOLLOW-UP AFTER 2-CHLORODEOXYADENOSINE (2CDA) TREATMENT IN 30 PATIENTS WITH HAIRY-CELL LEUKEMIA (HCL)", Blood, 88(10), 1996, pp. 2268-2268
24. MEUNIER P; CASTAIGNE S; BASTIE JN; CHOSIDOW O; ARACTINGI S
    CUTANEOUS REACTIONS AFTER TREATMENT WITH 2-CHLORODEOXYADENOSINE
    Acta dermato-venereologica
    
    P. Meunier et al., "CUTANEOUS REACTIONS AFTER TREATMENT WITH 2-CHLORODEOXYADENOSINE", Acta dermato-venereologica, 76(5), 1996, pp. 385-386
25. FENAUX P; CHASTANG C; CHOMIENNE C; CASTAIGNE S; SANZ M; LINK H; LOWENBERG B; FEY M; ARCHIMBAUD E; DEGOS L
    TREATMENT OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) BY ALL TRANSRETINOIC ACID (ATRA) COMBINED WITH CHEMOTHERAPY - THE EUROPEAN EXPERIENCE
    Leukemia & lymphoma
    
    P. Fenaux et al., "TREATMENT OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) BY ALL TRANSRETINOIC ACID (ATRA) COMBINED WITH CHEMOTHERAPY - THE EUROPEAN EXPERIENCE", Leukemia & lymphoma, 16(5-6), 1995, pp. 431-437
26. DOMBRET H; GEIGER S; DANIEL MT; GLAISNER S; MICLEA JM; CASTAIGNE S; MERLEBERAL H; LACOMBE C; CHOMIENNE C; DEGOS L
    CHANGES IN MICRORHEOLOGY OF ACUTE PROMYELOCYTIC LEUKEMIA-CELLS DURINGALL-TRANS-RETINOIC ACID (ATRA) DIFFERENTIATION THERAPY - A MECHANISM FOR ATRA-INDUCED HYPERLEUKOCYTOSIS
    Leukemia
    
    H. Dombret et al., "CHANGES IN MICRORHEOLOGY OF ACUTE PROMYELOCYTIC LEUKEMIA-CELLS DURINGALL-TRANS-RETINOIC ACID (ATRA) DIFFERENTIATION THERAPY - A MECHANISM FOR ATRA-INDUCED HYPERLEUKOCYTOSIS", Leukemia, 9(9), 1995, pp. 1473-1477
27. DOMBRET H; SCROBOHACI ML; DANIEL MT; MICLEA JM; CASTAIGNE S; CHOMIENNE C; FENAUX P; DEGOS L
    IN-VIVO THROMBIN AND PLASMIN ACTIVITIES IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL) - EFFECT OF ALL-TRANS-RETINOIC ACID (ATRA) THERAPY
    Leukemia
    
    H. Dombret et al., "IN-VIVO THROMBIN AND PLASMIN ACTIVITIES IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL) - EFFECT OF ALL-TRANS-RETINOIC ACID (ATRA) THERAPY", Leukemia, 9(1), 1995, pp. 19-24
28. SCROBOHACI ML; DOMBRET H; DANIEL MT; CASTAIGNE S; CHOMIENNE C; FENAUX P; DEGOS L
    IN-VIVO THROMBIN AND PLASMIN ACTIVITIES IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL) - EFFECT OF ALL-TRANS-RETINOIC ACID (ATRA) THERAPY
    Thrombosis and haemostasis
    
    M.L. Scrobohaci et al., "IN-VIVO THROMBIN AND PLASMIN ACTIVITIES IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL) - EFFECT OF ALL-TRANS-RETINOIC ACID (ATRA) THERAPY", Thrombosis and haemostasis, 73(6), 1995, pp. 1433-1433
29. AZAGURY M; DOMBRET H; CASTAIGNE S; DEGOS L
    GROWTH-HORMONE AND ACUTE PROMYELOCYTIC LEUKEMIA
    Medical and pediatric oncology
    
    M. Azagury et al., "GROWTH-HORMONE AND ACUTE PROMYELOCYTIC LEUKEMIA", Medical and pediatric oncology, 24(1), 1995, pp. 69-70
30. JOURDAN E; DOMBRET H; GLAISNER S; MICLEA JM; CASTAIGNE S; DEGOS L
    UNEXPECTED HIGH-INCIDENCE OF INTRACRANIAL SUBDURAL-HEMATOMA DURING INTENSIVE CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA WITH A MONOBLASTIC COMPONENT
    British Journal of Haematology
    
    E. Jourdan et al., "UNEXPECTED HIGH-INCIDENCE OF INTRACRANIAL SUBDURAL-HEMATOMA DURING INTENSIVE CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA WITH A MONOBLASTIC COMPONENT", British Journal of Haematology, 89(3), 1995, pp. 527-530
31. DEGOS L; DOMBRET H; CHOMIENNE C; DANIEL MT; MICLEA JM; CHASTANG C; CASTAIGNE S; FENAUX P
    ALL-TRANS-RETINOIC ACID AS A DIFFERENTIATING AGENT IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
    Blood
    
    L. Degos et al., "ALL-TRANS-RETINOIC ACID AS A DIFFERENTIATING AGENT IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA", Blood, 85(10), 1995, pp. 2643-2653
32. ROUSSELOT P; HARDAS B; PATEL A; GUIDEZ F; GAKEN J; CASTAIGNE S; DEJEAN A; DETHE H; DEGOS L; FARZANEH F; CHOMIENNE C
    THE PML-RAR-ALPHA GENE-PRODUCT OF THE T(1517) TRANSLOCATION INHIBITS RETINOIC ACID-INDUCED GRANULOCYTIC DIFFERENTIATION AND MEDIATED TRANSACTIVATION IN HUMAN MYELOID CELLS
    Oncogene
    
    P. Rousselot et al., "THE PML-RAR-ALPHA GENE-PRODUCT OF THE T(1517) TRANSLOCATION INHIBITS RETINOIC ACID-INDUCED GRANULOCYTIC DIFFERENTIATION AND MEDIATED TRANSACTIVATION IN HUMAN MYELOID CELLS", Oncogene, 9(2), 1994, pp. 545-551
33. COMIC M; DELVA L; CASTAIGNE S; LEFEBVRE P; BALITRAND N; DEGOS L; CHOMIENNE C
    IN-VITRO ALL-TRANS-RETINOIC ACID (ATRA) SENSITIVITY AND CELLULAR RETINOIC ACID-BINDING PROTEIN (CRABP) LEVELS IN RELAPSE LEUKEMIC-CELLS AFTER REMISSION INDUCTION BY ATRA IN ACUTE PROMYELOCYTIC LEUKEMIA
    Leukemia
    
    M. Comic et al., "IN-VITRO ALL-TRANS-RETINOIC ACID (ATRA) SENSITIVITY AND CELLULAR RETINOIC ACID-BINDING PROTEIN (CRABP) LEVELS IN RELAPSE LEUKEMIC-CELLS AFTER REMISSION INDUCTION BY ATRA IN ACUTE PROMYELOCYTIC LEUKEMIA", Leukemia, 8(6), 1994, pp. 914-917
34. BALITRAND N; SCHLAGETER MHL; DEGENTILE A; TOUBERT ME; KRAWICE I; FENAUX P; CASTAIGNE S; NAJEAN Y; DEGOS L; CHOMIENNE C
    MODULATION OF IL-8, IL-1-BETA, AND G-CSF SECRETION BY ALL-TRANS-RETINOIC ACID IN ACUTE PROMYELOCYTIC LEUKEMIA
    Leukemia
    
    N. Balitrand et al., "MODULATION OF IL-8, IL-1-BETA, AND G-CSF SECRETION BY ALL-TRANS-RETINOIC ACID IN ACUTE PROMYELOCYTIC LEUKEMIA", Leukemia, 8(10), 1994, pp. 1750-1757
35. DEGENTILE A; TOUBERT ME; DUBOIS C; KRAWICE I; SCHLAGETER MH; BALITRAND N; CASTAIGNE S; DEGOS L; RAIN JD; NAJEAN Y; CHOMIENNE C
    INDUCTION OF HIGH-AFFINITY GM-CSF RECEPTORS DURING ALL-TRANS-RETINOICACID TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
    Leukemia
    
    A. Degentile et al., "INDUCTION OF HIGH-AFFINITY GM-CSF RECEPTORS DURING ALL-TRANS-RETINOICACID TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA", Leukemia, 8(10), 1994, pp. 1758-1762
36. DOMBRET H; CASTAIGNE S; FENAUX P; CHOMIENNE C; DEGOS L
    INDUCTION TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA USING ALL-TRANS-RETINOIC ACID - CONTROVERSIES ABOUT DOSAGE, ADVANTAGES AND SIDE-EFFECT MANAGEMENT
    Leukemia
    
    H. Dombret et al., "INDUCTION TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA USING ALL-TRANS-RETINOIC ACID - CONTROVERSIES ABOUT DOSAGE, ADVANTAGES AND SIDE-EFFECT MANAGEMENT", Leukemia, 8, 1994, pp. 73-75
37. CORNIC M; DELVA L; CASTAIGNE S; LEFEBVRE P; BALITRAND N; DEGOS L; CHOMIENNE C
    IN-VITRO ALL-TRANS-RETINOIC ACID (ATRA) SENSITIVITY AND CELLULAR RETINOIC ACID-BINDING PROTEIN (CRABP) LEVELS IN RELAPSE LEUKEMIC-CELLS AFTER REMISSION INDUCTION BY ATRA IN ACUTE PROMYELOCYTIC LEUKEMIA
    Leukemia
    
    M. Cornic et al., "IN-VITRO ALL-TRANS-RETINOIC ACID (ATRA) SENSITIVITY AND CELLULAR RETINOIC ACID-BINDING PROTEIN (CRABP) LEVELS IN RELAPSE LEUKEMIC-CELLS AFTER REMISSION INDUCTION BY ATRA IN ACUTE PROMYELOCYTIC LEUKEMIA", Leukemia, 8, 1994, pp. 16-19
38. BRICE P; PAUTIER P; MAROLLEAU JP; CASTAIGNE S; GISSELBRECHT C
    PREGNANCY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MALIGNANT-LYMPHOMAS
    Nouvelle revue francaise d'hematologie
    
    P. Brice et al., "PREGNANCY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MALIGNANT-LYMPHOMAS", Nouvelle revue francaise d'hematologie, 36(5), 1994, pp. 387-388
39. CASTAIGNE S; ARCHIMBAUD E; FENAUX P; BORDESSOULE D; TILLY H; SIMON M; DUPRIEZ B; AUZANNEAU G; LEGROS M; TERTIAN G; JANVIER M; RENOUX M; SCHOENWALD M
    ROLE OF DOUBLE INDUCTION IN THE TREATMENT OF ACUTE MYELOBLASTIC-LEUKEMIA IN ADULTS - INTERIM RESULTS OF THE LAM90 PROTOCOL
    Nouvelle revue francaise d'hematologie
    
    S. Castaigne et al., "ROLE OF DOUBLE INDUCTION IN THE TREATMENT OF ACUTE MYELOBLASTIC-LEUKEMIA IN ADULTS - INTERIM RESULTS OF THE LAM90 PROTOCOL", Nouvelle revue francaise d'hematologie, 36, 1994, pp. 190000139-190000140
40. FENAUX P; WATTEL E; ARCHIMBAUD E; SANZ M; HECQUET B; FEGUEUX N; GUERCI A; LINK H; FEY M; CASTAIGNE S; DEGOS L
    PROLONGED FOLLOW-UP CONFIRMS THAT ALL-TRANS-RETINOIC ACID FOLLOWED BYCHEMOTHERAPY REDUCES THE RISK OF RELAPSE IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
    Blood
    
    P. Fenaux et al., "PROLONGED FOLLOW-UP CONFIRMS THAT ALL-TRANS-RETINOIC ACID FOLLOWED BYCHEMOTHERAPY REDUCES THE RISK OF RELAPSE IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA", Blood, 84(2), 1994, pp. 666-667
41. FENAUX P; CHASTANG C; CASTAIGNE S; ARCHIMBAUD E; SANZ M; LINK H; GUERCI A; FEGUEUX N; ZITTOUN R; STOPPA AM; TRAYADE P; LAMY T; MALOISEL F; SADOUN A; SANMIGUEL J; VEIL A; RAYON C; CONDE E; FEY M; BORDESSOULE D; GANSER A; BOWEN D; DREYFUS F; HUGUET F; TILLY H; GUY H; AUZANNEAU G; CHOMIENNE C; DEGOS L
    TREATMENT OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) WITH ALL TRANSRETINOIC ACID (ATRA) FOLLOWED BY INTENSIVE CHEMOTHERAPY (CT) - UPDATED RESULTS OF THE EUROPEAN GROUP
    Blood
    
    P. Fenaux et al., "TREATMENT OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) WITH ALL TRANSRETINOIC ACID (ATRA) FOLLOWED BY INTENSIVE CHEMOTHERAPY (CT) - UPDATED RESULTS OF THE EUROPEAN GROUP", Blood, 84(10), 1994, pp. 10000379-10000379
42. DUBOIS C; SCHLAGETER MH; DEGENTILE A; GUIDEZ F; BALITRAND N; TOUBERT ME; KRAWICE I; FENAUX P; CASTAIGNE S; NAJEAN Y; DEGOS L; CHOMIENNE C
    HEMATOPOIETIC GROWTH-FACTOR EXPRESSION AND ATRA SENSITIVITY IN ACUTE PROMYELOCYTIC BLAST CELLS
    Blood
    
    C. Dubois et al., "HEMATOPOIETIC GROWTH-FACTOR EXPRESSION AND ATRA SENSITIVITY IN ACUTE PROMYELOCYTIC BLAST CELLS", Blood, 83(11), 1994, pp. 3264-3270
43. FERME C; LEPAGE E; BRICE P; DAGAY MF; FERMAND JP; CASTAIGNE S; FRIJA J; MIOT C; MARTY M; GISSELBRECHT C
    COMBINED CHEMOTHERAPY-RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE - RESULTS OF A PROSPECTIVE CLINICAL-TRIAL WITH 70 STAGE IIIB-IV PATIENTS
    International journal of radiation oncology, biology, physics
    
    C. Ferme et al., "COMBINED CHEMOTHERAPY-RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE - RESULTS OF A PROSPECTIVE CLINICAL-TRIAL WITH 70 STAGE IIIB-IV PATIENTS", International journal of radiation oncology, biology, physics, 26(3), 1993, pp. 397-405
44. WANG ZY; CASTAIGNE S; BERNARD J; BESSIS B; CHOMIENNE C; BEUTLER E; CRONKITE EP; DETHE G; BINET JL; SACHS L; BULL B; DIGHIERO G; DETHE H
    PROBLEMS EXISTING IN DIFFERENTIATION THERAPY OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) WITH ALL-TRANS-RETINOIC ACID (ATRA) - DISCUSSION
    Blood cells
    
    Z.Y. Wang et al., "PROBLEMS EXISTING IN DIFFERENTIATION THERAPY OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) WITH ALL-TRANS-RETINOIC ACID (ATRA) - DISCUSSION", Blood cells, 19(3), 1993, pp. 642-647
45. DELVA L; CORNIC M; BALITRAND N; GUIDEZ F; MICLEA JM; DELMER A; TEILLET F; FENAUX P; CASTAIGNE S; DEGOS L; CHOMIENNE C
    RESISTANCE TO ALL-TRANS-RETINOIC ACID (ATRA) THERAPY IN RELAPSING ACUTE PROMYELOCYTIC LEUKEMIA - STUDY OF IN-VITRO ATRA SENSITIVITY AND CELLULAR RETINOIC ACID-BINDING PROTEIN-LEVELS IN LEUKEMIC-CELLS
    Blood
    
    L. Delva et al., "RESISTANCE TO ALL-TRANS-RETINOIC ACID (ATRA) THERAPY IN RELAPSING ACUTE PROMYELOCYTIC LEUKEMIA - STUDY OF IN-VITRO ATRA SENSITIVITY AND CELLULAR RETINOIC ACID-BINDING PROTEIN-LEVELS IN LEUKEMIC-CELLS", Blood, 82(7), 1993, pp. 2175-2181
46. CASTAIGNE S; LEFEBVRE P; CHOMIENNE C; SUC E; RIGALHUGUET F; GARDIN C; DELMER A; ARCHIMBAUD E; TILLY H; JANVIER M; ISNARD F; TRAVADE P; MONTFORT L; DELANNOY A; RAPP MJ; CHRISTIAN B; MONTASTRUC M; WEH H; FENAUX P; DOMBRET H; GOURMEL B; DEGOS L
    EFFECTIVENESS AND PHARMACOKINETICS OF LOW-DOSE ALL-TRANS-RETINOIC ACID (25 MG M2) IN ACUTE PROMYELOCYTIC LEUKEMIA/
    Blood
    
    S. Castaigne et al., "EFFECTIVENESS AND PHARMACOKINETICS OF LOW-DOSE ALL-TRANS-RETINOIC ACID (25 MG M2) IN ACUTE PROMYELOCYTIC LEUKEMIA/", Blood, 82(12), 1993, pp. 3560-3563
47. FENAUX P; LEDELEY MC; CASTAIGNE S; ARCHIMBAUD E; CHOMIENNE C; LINK H; GUERCI A; DUARTE M; DANIEL MT; BOWEN D; HUEBNER G; BAUTERS F; FEGUEUX N; FEY M; SANZ M; LOWENBERG B; MALOISEL F; AUZANNEAU G; SADOUN A; GARDIN C; BASTION Y; GANSER A; JACKY E; DOMBRET H; CHASTANG C; DEGOS L
    EFFECT OF ALL TRANSRETINOIC ACID IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA - RESULTS OF A MULTICENTER RANDOMIZED TRIAL
    Blood
    
    P. Fenaux et al., "EFFECT OF ALL TRANSRETINOIC ACID IN NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA - RESULTS OF A MULTICENTER RANDOMIZED TRIAL", Blood, 82(11), 1993, pp. 3241-3249
48. DOMBRET H; RENESTO P; SCROBOHACI ML; GUERCI AP; BARUCHEL A; MOLINA L; RAPP MJ; CORDONNIER C; CASTAIGNE S; DEGOS L
    PLASMA-FREE SERINE-PROTEASE ACTIVITY (SPA) IN PATIENTS WITH ACUTE PRMYELOCYTIC LEUKEMIA (APL) - EFFECT OF ALL-TRANS-RETINOIC ACID (ATRA) THERAPY
    Blood
    
    H. Dombret et al., "PLASMA-FREE SERINE-PROTEASE ACTIVITY (SPA) IN PATIENTS WITH ACUTE PRMYELOCYTIC LEUKEMIA (APL) - EFFECT OF ALL-TRANS-RETINOIC ACID (ATRA) THERAPY", Blood, 82(10), 1993, pp. 10000249-10000249
49. DUBOIS C; SCHLAGETHER MH; GUIDEZ F; BALITRAND N; DEGENTILLE A; TOUBERT ME; FENAUX P; CASTAIGNE S; NAJEAN Y; DEGOS L
    CYTOKINE SECRETION STUDIES IN APL CELLS - MEANS TO EVALUATE ATRA INDUCED-DIFFERENTIATION AND PROLIFERATION
    Blood
    
    C. Dubois et al., "CYTOKINE SECRETION STUDIES IN APL CELLS - MEANS TO EVALUATE ATRA INDUCED-DIFFERENTIATION AND PROLIFERATION", Blood, 82(10), 1993, pp. 10000538-10000538